期刊文献+

肺部穿刺活检联合血清SCC、CEA、NSE诊断肺癌的价值 被引量:7

Value of lung biopsy combined with SCC,CEA and NSE in the diagnosis of lung cancer
下载PDF
导出
摘要 目的探讨肺部穿刺活检联合鳞癌抗原(SCC)、癌胚抗原(CEA)、神经元特异度烯醇化酶(NSE)检测诊断肺癌的价值分析.方法选取本院2016年1月至2020年4月就诊的90例确诊肺癌患者为观察组,选取同时期来院就诊的90例肺部良性病变患者及90例健康体检者分别作为良性组与对照组,比较3组血清SCC、CEA、NSE水平,同时分析观察组不同病理类型、分期上述指标的差异,分析肺部穿刺活检、血清SCC、CEA、NSE单独及联合检测在肺癌诊断中的价值.结果观察组血清SCC、CEA、NSE水平均高于良性组及对照组(P<0.05);肺鳞癌者血清SCC水平较肺腺癌及小细胞肺癌明显升高(P<0.05);小细胞肺癌者血清NSE水平较肺腺癌及肺鳞癌明显升高(P<0.05);肺腺癌者血清CEA水平较肺鳞癌及小细胞肺癌明显升高(P<0.05);周围型肺癌穿刺活检阳性率为94.64%,并发症发生率为25.56%;穿刺活检联合SCC、CEA、NSE检测诊断肺癌的敏感度95.56%,特异度100%.结论肺部穿刺活检诊断周围型肺癌阳性率高,并发症少,联合SCC、CEA、NSE检测能提高诊断肺癌的敏感度与特异度,具有较高临床价值. Objective To study the value of lung biopsy combined with SCC,CEA and NSE in the diagnosis of lung cancer.Methods Ninety patients with lung cancer in our hospital from January 2016 to April 2020 were selected as the observa-tion group,and 90 patients with pulmonary benign disease and 90 healthy persons were selected as benign group and control group respectively.The serum levels of SCC,CEA and NSE in the three groups were compared,and the differences of the above indexes in different pathological types and stages of the observation group were analyzed,and the value of lung biopsy and serum three separate and com bined detection in the diagnosis of lung cancer was analyzed.Results The serum levels of SCC,CEA and NSE in the observation group were higher than those in the benign group or the control group(P<0.05);the serum SCC level of patients with lung squamous cell carcinoma was significantly higher than that of lung adenocarcinoma and small cell lung canc-er(P<0.05);the serum NSE level of small cell lung cancer was significantly higher than that of lung adenocarcinoma and small cell lung cancer(P<0.05);the serum CEA level of lung adenocarcinoma was significantly higher than that of lung squamous cell carcinoma and small cell lung cancer(P<0.05).The positive rate of biopsy was 94.64%and the incidence of complications was 25.56%.The sensitivity and specificity of biopsy combined with SCC,CEA and NSE were 95.56%and 100%,respective-ly.Conclusion Lung biopsy has high positive rate and less complications in the diagnosis of peripheral lung cancer.Combined detection of SCC,CEA and NSE can improve the sensitivity and specificity of diagnosis of lung cancer,and has high clinical val-ue.
作者 李天林 余薇 陈亮 李远鹏 黄馨莹 许东平 刘俊安 LI Tianlin;YU Wei;CHEN Liang;LI Yuanpeng;HUANG Xinying;XU Dongping;LIU Junan(Department of Respiratory,Xiamen Changgeng Hospital Affiliated to Huaqiao University,Xiamen,Fujian 361028,China)
出处 《福建医药杂志》 CAS 2021年第3期26-29,共4页 Fujian Medical Journal
关键词 肺部穿刺活检 鳞癌抗原 癌胚抗原 肺癌 临床价值 lung biopsy SCC CEA lung cancer clinical value
  • 相关文献

参考文献7

二级参考文献71

  • 1郑晓霞,李琼珍,李玲,胥琳璟.宫颈癌预后状况及其影响因素分析[J].实用癌症杂志,2014,29(3):314-316. 被引量:56
  • 2刘馨,白艳香.血清肿瘤标志物和宫颈癌分期的相关性及其机制[J].中国老年学杂志,2014,34(11):2945-2946. 被引量:10
  • 3谭诗生,李杭,罗健,陈南江,宋毅,姜桂林,杨飞月.欧洲癌症研究与治疗组织研制的生活质量核心调查问卷第3版中文版生活质量调查问卷测评[J].中国临床康复,2006,10(4):23-27. 被引量:303
  • 4Marcos Duarte Guimaraes,Marcony Queiroz de Andrade,Alexandre Calabria da Fonte,Rubens Chojniak,Jefferson Luiz Gross.CT-guided cutting needle biopsy of lung lesions—An effective procedure for adequate material and specific diagnose[J]. European Journal of Radiology . 2010 (3)
  • 5Grilley-Olson JE,Hayes DN,Moore DT,et al.Validation of interobserver agreement in lung cancer assessment:hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer:the 2004World Health Organization classification and therapeutically relevant subsets[J].Arch Pathol Lab Med,2013,137(1):32-40.
  • 6Schoellnast H,Deodhar A,Hsu M,et al.Recurrent non-small cell lung cancer:Evaluation of CT-guided radiofrequency ablation as salvage therapy[J].Acta Radiol,2012,53(8):893-899.
  • 7Yang Z,Chevolot Y,Géhin T,et al.Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays:Application to the sensitive and specific detection of tumor markers from breast cancer sera[J].Biosens Bioelectron,2013,40(1):385-392.
  • 8Yu DH,Li JH,Wang YC,et al.Serum anti-p53 antibody detection in carcinomas and the predictive values of serum p53 antibodies,carcino-embryonic antigen and carbohydrate antigen 12-5 in the neoadjuvant chemotherapy treatment for III stage non-small cell lung cancer patients[J].Clin Chim Acta,2011,412(11/12):930-935.
  • 9Takahashi H,Kurishima K,Ishikawa H,et al.Optimal cutoff points of CYFRA21-1 for survival prediction in non-small cell lung cancer patients based on running statistical analysis[J].Anticancer Res,2010,30(9):3833-3837.
  • 10Chen Q,Ge F,Cui W,et al.Lung cancer circulating tumor cells isolated by the Ep CAM-independent enrichment strategy correlate with Cytokeratin 19-derived CYFRA21-1 and pathological staging[J].Clin Chim Acta,2013,419:57-61.

共引文献122

同被引文献96

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部